GHK Cu FDA Approval Status 2026: Not Approved GHK Cu Engage Peptides BREAKING NEWS: HHS @seckennedy just announced that the FDA is taking a step toward restoring science based access by removing 12 peptides from Category 2. FDA is moving them to an independent scientific Potential FDA Peptide Reclassification 2026 What It Means for Patients Beverly Hills Rejuvenation Center January 2026 FDA New Drug Approvals Zycubo (copper histidinate) Some approvals mark progress. Others redefine what hope looks like. In January 2026, the U.S. FDA approved Zycubo (copper histidinate injection formerly